Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 220
Aptamer sequence: TGGTTGGTTTTTGGTTTTTTTTTTTGGTTT
Target unique ID: P04585
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_216 PF1T Protein POL_HV1H2 448 nM 50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes 22554064
Structure information of aptamer
Aptamer Sequence: TGGTTGGTTTTTGGTTTTTTTTTTTGGTTT
The optimal secondary structure in dot-bracket notation: ..............................
The centroid secondary structure in dot-bracket notation: ..............................
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_216 Description PF1T
Aptamer chemistry DNA Length 30 nt
GC content 26.7% Molecular weight 9,503.87 Da
Molarity of 1 μg/μl solution 105.22 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence TGGTTGGTTTTTGGTTTTTTTTTTTGGTTT
Applications Inhibiting function against the WT HIV-1 RT
Target information
Type Detail Type Detail
Uniprot ID P04585 Protein name Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Gene name(s) gag-pol Organism Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Status reviewed in uniprot database Length 1435
Mass 162,042 Activity regulation The viral protease is inhibited by many synthetic protease inhibitors (PIs), such as amprenavir, atazanavir, indinavir, loprinavir, nelfinavir, ritonavir and saquinavir
Involvement in disease N/A Catalytic activity Reaction=Specific for a P1 residue that is hydrophobic, and P1' variable
PDB ID(s)
1A30;1BV7;1BV9;1BVE;1BVG;1BWA;1BWB;1C0T;1C0U;1C1B;1C1C;1DMP;1DTQ;1DTT;1E6J;1EP4;1ESK;1EX4;1EXQ;1FB7;1FK9;1FKO;1FKP;1G6L;1HIV;1HVH;1HVR;1HWR;1HXB;1JKH;1JLA;1JLB;1JLC;1JLE;1JLF;1JLG;1JLQ;1KLM;1LV1;1LW0;1LW2;1LWC;1LWE;1LWF;1NCP;1O1W;1ODW;1ODY;1QBR;1QBS;1QBT;1QBU;1REV;1RT1;1RT2;1RT3;1RT4;1RT5;1RT6;1RT7;1RTD;1RTH;1RTI;1RTJ;1S1T;1S1U;1S1V;1S1W;1S1X;1T05;1TAM;1TKT;1TKX;1TKZ;1TL1;1TL3;1VRT;1VRU;2HND;2HNY;2HNZ;2KOD;2NPH;2OPP;2OPQ;2OPR;2OPS;2RF2;2RKI;2WHH;2WOM;2WON;2YNF;2YNG;2YNH;2YNI;3AO2;3C6T;3C6U;3DI6;3DLE;3DLG;3DM2;3DMJ;3DOK;3DOL;3DOX;3DRP;3DRR;3DRS;3DYA;3E01;3FFI;3I0R;3I0S;3KJV;3KK1;3KK2;3KK3;3KT2;3KT5;3LAK;3LAL;3LAM;3LAN;3LP0;3LP1;3LP2;3M8P;3M8Q;3MEC;3MED;3MEE;3MEG;3N3I;3NBP;3PHV;3QIN;3QIO;3QIP;3T19;3T1A;3TAM;4B3O;4B3P;4B3Q;4I7F;4KSE;4KV8;4NCG;4Q1W;4Q1X;4Q1Y;4Q5M;4QLH;4U1H;4U1I;4U1J;4U7Q;4U7V;5DGU;5DGW;5EU7;5HRN;5HRP;5HRR;5HRS;5IM7;5J2M;5J2N;5J2P;5J2Q;5K14;5KAO;5T82;5TC2;5VZ6;5XOS;5XOT;5YRS;6BJ2;6BJ3;6BSG;6BSH;6BSI;6BSJ;6DIF;6DIL;6DJ1;6DJ2;6DJ5;6DJ7;6DV0;6DV4;6E7J;6E9A;6EWA;6EX9;6GL1;6J1V;6J1W;6OR7;6OTZ;6P1I;6P1X;6P2G;6PYL;6SKK;6SKM;6SKN;6SLQ;6SLU;6SMU;6UIR;6UIS;6UIT;6UJX;6UJY;6UJZ;6UK0;6VPZ;6VQ2;6VQD;6VQE;6VQY;6VQZ;6WAZ;6WB1;6WPF;6WPH;6WPJ;
Function Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane.
Activity data

No relevant experimental diagram

Interaction ID 220
Target type Protein
Target unique ID P04585
Activity 448 nM
Binding Conditions/Buffer

50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes

Assay

N/A

PubMed ID 22554064
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_482 DNA AGCAAGGTTTGGTGTTGGTTGGTTGCTGGTTTTGGTTTC 64.10%
Apta_1238 DNA GGTTTTGTGTTTGTGTTTTGTGGTTGTTGT 63.33%
Apta_1155 DNA TAGTTTTATTTGTTCATTTTGTGTATTGTTTTGA 61.76%
Apta_1236 DNA GGACTGTTGTGGTATTATTTTTGGTTGTGC 60.00%
Apta_1243 DNA GGTGTTGTTGTTGGCTAGTTTGTTGTGGGC 60.00%
Apta_1247 DNA GGTGGTTGCTGTTGTTTGTGGTTGGTGTGC 60.00%
Apta_564 DNA GGGGACTGTTGTGGTATTATTTTTGGTTGTGCAGT 57.14%
Apta_350 DNA GGTGGTGGTGGTTGTGGTGGTGGTGG 56.67%
Apta_809 DNA GGGTACGTATTTGGTTTATAGATAGTAA 56.67%
Apta_1241 DNA GGTGTGGAGTGGTGTGTGTTGTTGTTTGTC 56.67%
Apta_1154 DNA TTAATTTTTTGATCTTTGATTGTTTTATTTTTTTTATTGTTTGTG 55.56%
Apta_35 DNA TGGGTGGCCTCCCGTTTATTCGAGATTTGGTTGAATTTGT 55.00%
Apta_285 DNA GCCACTCCGTCACTTTAGTGGTTTTTTTTATAAATGCTTC 55.00%
Apta_914 DNA CGCTCCGTTTACTCGGTCTGCTATTGGCTTGCCTTTGTTT 55.00%
Apta_916 DNA GGCGTATGCAGTTTTGTAGGGTTATCAAGGCTTGACGATT 55.00%
Apta_1205 DNA GGCAGGTGGTGTTGGTTGGTTGTGCGTGGAGTTGG 54.29%
Apta_184 DNA AGGAAGGCTTTAGGTCTGAGATCTCGGAAT 53.33%
Apta_757 DNA GGTGGTGGTGGTTGTGGTGGTGG 53.33%
Apta_1085 DNA TGGGGTGGTGGTGTGGGTGGGGGTTTGTTC 53.33%
Apta_1239 DNA GGTGGATGGGGATGCTTTGTTAGTTTGTGC 53.33%